Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Inkwood Research | PRODUCT CODE: 1069196

Cover Image

PUBLISHER: Inkwood Research | PRODUCT CODE: 1069196

Europe Biomaterials Market Forecast 2022-2030

PUBLISHED:
PAGES: 162 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 1600
PDF (Corporate License)
USD 2200

Add to Cart

KEY FINDINGS

The Europe biomaterials market is estimated to rise with a CAGR of 12.62% during the forecast period, 2022-2030. The market growth is expected to be driven by technological transformations and changing healthcare ecosystems with the adoption of advanced and effective technologies.

MARKET INSIGHTS

The Europe biomaterials market growth evaluation entails the assessment of Italy, Russia, United Kingdom, Belgium, France, Poland, Germany, and Rest of Europe. In France, various organizations focus on researching biomaterial implants and tissue engineering. Moreover, the increasing geriatric population, the surge in prevalence of chronic diseases, and the presence of various research organizations are found to increase the demand for biomaterials in the region.

Furthermore, the Italy biomaterials market growth is stimulated by increasing demand from orthopedic, cardiovascular, ophthalmology, wound healing, dental, plastic surgery, tissue engineering, and neurological & central nervous system. However, the regional market lacks the presence of key players. But with increased funding and the rising interest in adopting cosmetic procedures, the biomaterials market is expected to grow in Italy.

In addition, Russia represents a very attractive market for developing biomaterials, given its extensive renewable energy assets and country-wide range of consumers. Major players operating in Russia are banking upon aggressive marketing and innovations strategies to cater to a wide range of consumers operating in the region. The improved socio-economic conditions and the modernization of consumption patterns in Russia are also anticipated to propel the demand for biomaterials in the country.

COMPETITIVE INSIGHTS

Some prominent market players in the market include: Noble Biomaterials Inc, Royal DSM, BASF, Mitsubishi Chemical Holdings Corporation, Covestro AG, Collagen Solutions PLC, Zimmer Biomet Holdings Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 44117

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. USAGE OF BIOMATERIALS IN BONE FIXATION AND PLASTIC SURGERIES
    • 3.1.2. PREVALENCE OF GERIATRIC POPULATION AND CARDIOVASCULAR DISEASES
    • 3.1.3. GOVERNMENT SUPPORT FOR RESEARCH AND DEVELOPMENT INITIATIVES
    • 3.1.4. APPLICATIONS OF BIOMATERIALS IN PLASTIC SURGERIES AND WOUND HEALING THERAPIES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. BIOCOMPATIBILITY ISSUES ASSOCIATED WITH BIOMATERIAL
    • 3.2.2. STRINGENT REGULATIONS
    • 3.2.3. HIGH PRICE OF THE IMPLANTABLE BIOMATERIALS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON BIOMATERIALS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS

5. MARKET BY PRODUCT

  • 5.1. METAL-BASED BIOMATERIALS
    • 5.1.1. STAINLESS STEEL
    • 5.1.2. TITANIUM AND TITANIUM ALLOYS
    • 5.1.3. CO-CR ALLOYS
    • 5.1.4. MAGNESIUM
    • 5.1.5. GOLD
    • 5.1.6. SILVER
    • 5.1.7. NITINOL
    • 5.1.8. OTHER METAL-BASED BIOMATERIALS
  • 5.2. POLYMER-BASED BIOMATERIALS
    • 5.2.1. PMMA
    • 5.2.2. POLYETHYLENE TEREPHTHALATE
    • 5.2.3. POLYESTER
    • 5.2.4. POLYVINYLCHLORIDE
    • 5.2.5. SILICONE RUBBER
    • 5.2.6. NYLON
    • 5.2.7. POLYETHERETHERKETONE
    • 5.2.8. OTHER POLYMER-BASED BIOMATERIALS
  • 5.3. CERAMIC-BASED BIOMATERIALS
    • 5.3.1. CALCIUM PHOSPHATE
    • 5.3.2. ALUMINUM OXIDE
    • 5.3.3. CALCIUM SULFATE
    • 5.3.4. ZIRCONIA
    • 5.3.5. CARBON
    • 5.3.6. GLASS
  • 5.4. NATURAL BIOMATERIALS
    • 5.4.1. HYALURONIC ACID
    • 5.4.2. FIBRIN
    • 5.4.3. COLLAGEN & GELATIN
    • 5.4.4. CELLULOSE
    • 5.4.5. CHITIN
    • 5.4.6. ALGINATES
    • 5.4.7. SILK
  • 5.5. INORGANIC GLASS-BASED BIOMATERIALS
  • 5.6. RADIOPAQUE BIOMATERIALS
  • 5.7. REGENERATIVE BIOMATERIALS
  • 5.8. HYBRID BIOMATERIAL COMBINATIONS

6. MARKET BY APPLICATION

  • 6.1. CARDIOVASCULAR
    • 6.1.1. CATHETERS
    • 6.1.2. STENTS
    • 6.1.3. HEART VALVES
    • 6.1.4. PACEMAKERS
    • 6.1.5. IMPLANTABLE CARDIAC DEFIBRILLATORS
    • 6.1.6. VASCULAR GRAFTS
    • 6.1.7. GUIDEWIRES
    • 6.1.8. SENSORS
  • 6.2. ORTHOPEDIC
    • 6.2.1. JOINT REPLACEMENT
    • 6.2.2. FRACTURE FIXATION
    • 6.2.3. SPINE ADJUSTMENTS
    • 6.2.4. ORTHOBIOLOGY
    • 6.2.5. VISCOSUPPLEMENTATION
    • 6.2.6. BIORESORBABLE TISSUE FIXATION
  • 6.3. OPHTHALMOLOGY
    • 6.3.1. CONTACT LENSES
    • 6.3.2. INTRAOCULAR LENSES
    • 6.3.3. FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
    • 6.3.4. SYNTHETIC CORNEAS
    • 6.3.5. OTHER OPHTHALMOLOGY APPLICATIONS
  • 6.4. DENTAL
    • 6.4.1. DENTAL BONE GRAFTS AND SUBSTITUTES
    • 6.4.2. DENTAL MEMBRANES
  • 6.5. WOUND HEALING
    • 6.5.1. STAPLES
    • 6.5.2. WOUND CLOSURE DEVICES
    • 6.5.3. SUTURES
    • 6.5.4. HERNIA MESHES
    • 6.5.5. SURGICAL HAEMOSTATS
    • 6.5.6. INTERNAL TISSUE SEALANTS
    • 6.5.7. ADHESION BARRIERS
  • 6.6. PLASTIC SURGERIES
    • 6.6.1. CRANIOFACIAL SURGERIES
    • 6.6.2. SOFT-TISSUE FILLERS
  • 6.7. NEUROLOGICAL/CENTRAL NERVOUS SYSTEM
    • 6.7.1. SHUNTING SYSTEMS
    • 6.7.2. NEURAL STEM CELL ENCAPSULATION
    • 6.7.3. CORTICAL NEURAL PROSTHETICS (CNP)
    • 6.7.4. HYDROGEL SCAFFOLDS
  • 6.8. TISSUE ENGINEERING
    • 6.8.1. TAILORING OF INORGANIC NANOPARTICLES
    • 6.8.2. SCAFFOLDS FOR REGENERATIVE MEDICINES
    • 6.8.3. NANOMATERIAL FOR BIOSENSING
  • 6.9. OTHER APPLICATIONS
    • 6.9.1. URINARY APPLICATIONS
    • 6.9.2. DRUG DELIVERY SYSTEMS
    • 6.9.3. BARIATRIC SURGERIES
    • 6.9.4. GASTROINTESTINAL APPLICATIONS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. EUROPE
    • 7.1.1. MARKET SIZE & ESTIMATES
    • 7.1.2. KEY GROWTH ENABLERS
    • 7.1.3. KEY CHALLENGES
    • 7.1.4. KEY PLAYERS
    • 7.1.5. COUNTRY ANALYSIS
      • 7.1.5.1. UNITED KINGDOM
      • 7.1.5.2. GERMANY
      • 7.1.5.3. FRANCE
      • 7.1.5.4. ITALY
      • 7.1.5.5. RUSSIA
      • 7.1.5.6. BELGIUM
      • 7.1.5.7. POLAND
      • 7.1.5.8. REST OF EUROPE

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS & AGREEMENTS
    • 8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 8.2. COMPANY PROFILES
    • 8.2.1. BASF
    • 8.2.2. BBS-BIOACTIVE BONE SUBSTITUTES
    • 8.2.3. BIORETEC LTD
    • 8.2.4. CARPENTER TECHNOLOGY CORPORATION
    • 8.2.5. CELANESE CORPORATION
    • 8.2.6. COLLAGEN SOLUTIONS PLC
    • 8.2.7. CORBION NV
    • 8.2.8. COVESTRO AG
    • 8.2.9. DENTSPLY SIRONA
    • 8.2.10. EVONIK INDUSTRIES
    • 8.2.11. MITSUBISHI CHEMICAL HOLDINGS CORPORATION
    • 8.2.12. NOBLE BIOMATERIALS INC
    • 8.2.13. ROYAL DSM
    • 8.2.14. VICTREX PLC
    • 8.2.15. WRIGHT MEDICAL GROUP NV
    • 8.2.16. ZIMMER BIOMET HOLDINGS INC
Product Code: 44117

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BIOMATERIALS
  • TABLE 2: GERIATRIC POPULATION ACROSS DIFFERENT REGIONS (60 YEARS & ABOVE)
  • TABLE 3: EUROPE BIOMATERIALS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 4: EUROPE BIOMATERIALS MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 5: EUROPE BIOMATERIALS MARKET, BY METAL-BASED BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 6: EUROPE BIOMATERIALS MARKET, BY METAL-BASED BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 7: EUROPE BIOMATERIALS MARKET, BY POLYMER-BASED BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 8: EUROPE BIOMATERIALS MARKET, BY POLYMER-BASED BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 9: EUROPE BIOMATERIALS MARKET, BY CERAMIC-BASED BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 10: EUROPE BIOMATERIALS MARKET, BY CERAMIC-BASED BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 11: EUROPE BIOMATERIALS MARKET, BY NATURAL BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 12: EUROPE BIOMATERIALS MARKET, BY NATURAL BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 13: EUROPE BIOMATERIALS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 14: EUROPE BIOMATERIALS MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 15: EUROPE BIOMATERIALS MARKET, BY CARDIOVASCULAR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 16: EUROPE BIOMATERIALS MARKET, BY CARDIOVASCULAR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 17: EUROPE BIOMATERIALS MARKET, BY ORTHOPEDIC, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 18: EUROPE BIOMATERIALS MARKET, BY ORTHOPEDIC, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 19: EUROPE BIOMATERIALS MARKET, BY OPHTHALMOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 20: EUROPE BIOMATERIALS MARKET, BY OPHTHALMOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 21: EUROPE BIOMATERIALS MARKET, BY DENTAL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 22: EUROPE BIOMATERIALS MARKET, BY DENTAL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 23: EUROPE BIOMATERIALS MARKET, BY WOUND HEALING, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 24: EUROPE BIOMATERIALS MARKET, BY WOUND HEALING, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 25: EUROPE BIOMATERIALS MARKET, BY PLASTIC SURGERIES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 26: EUROPE BIOMATERIALS MARKET, BY PLASTIC SURGERIES, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 27: EUROPE BIOMATERIALS MARKET, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 28: EUROPE BIOMATERIALS MARKET, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 29: EUROPE BIOMATERIALS MARKET, BY TISSUE ENGINEERING, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 30: EUROPE BIOMATERIALS MARKET, BY TISSUE ENGINEERING, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 31: EUROPE BIOMATERIALS MARKET, BY OTHER APPLICATIONS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 32: EUROPE BIOMATERIALS MARKET, BY OTHER APPLICATIONS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 33: EUROPE BIOMATERIALS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 34: EUROPE BIOMATERIALS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 35: LEADING PLAYERS OPERATING IN THE EUROPE BIOMATERIALS MARKET
  • TABLE 36: LIST OF MERGERS & ACQUISITIONS
  • TABLE 37: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 38: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 39: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: PLASTIC SURGERIES PROCEDURES PERFORMED IN VARIOUS COUNTRIES IN 2019
  • FIGURE 2: KEY MARKET TRENDS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: VALUE CHAIN ANALYSIS
  • FIGURE 7: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
  • FIGURE 8: EUROPE BIOMATERIALS MARKET, BY METAL-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
  • FIGURE 9: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY METAL-BASED BIOMATERIALS, IN 2021
  • FIGURE 10: EUROPE BIOMATERIALS MARKET, BY STAINLESS STEEL, 2022-2030 (IN $ MILLION)
  • FIGURE 11: EUROPE BIOMATERIALS MARKET, BY TITANIUM AND TITANIUM ALLOYS, 2022-2030 (IN $ MILLION)
  • FIGURE 12: EUROPE BIOMATERIALS MARKET, BY CO-CR ALLOYS, 2022-2030 (IN $ MILLION)
  • FIGURE 13: EUROPE BIOMATERIALS MARKET, BY MAGNESIUM, 2022-2030 (IN $ MILLION)
  • FIGURE 14: EUROPE BIOMATERIALS MARKET, BY GOLD, 2022-2030 (IN $ MILLION)
  • FIGURE 15: EUROPE BIOMATERIALS MARKET, BY SILVER, 2022-2030 (IN $ MILLION)
  • FIGURE 16: EUROPE BIOMATERIALS MARKET, BY NITINOL, 2022-2030 (IN $ MILLION)
  • FIGURE 17: EUROPE BIOMATERIALS MARKET, BY OTHER METAL-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
  • FIGURE 18: EUROPE BIOMATERIALS MARKET, BY POLYMER-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
  • FIGURE 19: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY POLYMER-BASED BIOMATERIALS, IN 2021
  • FIGURE 20: EUROPE BIOMATERIALS MARKET, BY PMMA, 2022-2030 (IN $ MILLION)
  • FIGURE 21: EUROPE BIOMATERIALS MARKET, BY POLYETHYLENE TEREPHTHALATE, 2022-2030 (IN $ MILLION)
  • FIGURE 22: EUROPE BIOMATERIALS MARKET, BY POLYESTER, 2022-2030 (IN $ MILLION)
  • FIGURE 23: EUROPE BIOMATERIALS MARKET, BY POLYVINYLCHLORIDE, 2022-2030 (IN $ MILLION)
  • FIGURE 24: EUROPE BIOMATERIALS MARKET, BY SILICONE RUBBER, 2022-2030 (IN $ MILLION)
  • FIGURE 25: EUROPE BIOMATERIALS MARKET, BY NYLON, 2022-2030 (IN $ MILLION)
  • FIGURE 26: EUROPE BIOMATERIALS MARKET, BY POLYETHERETHERKETONE, 2022-2030 (IN $ MILLION)
  • FIGURE 27: EUROPE BIOMATERIALS MARKET, BY OTHER POLYMER-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
  • FIGURE 28: EUROPE BIOMATERIALS MARKET, BY CERAMIC-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
  • FIGURE 29: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY CERAMIC-BASED BIOMATERIALS, IN 2021
  • FIGURE 30: EUROPE BIOMATERIALS MARKET, BY CALCIUM PHOSPHATE, 2022-2030 (IN $ MILLION)
  • FIGURE 31: EUROPE BIOMATERIALS MARKET, BY ALUMINUM OXIDE, 2022-2030 (IN $ MILLION)
  • FIGURE 32: EUROPE BIOMATERIALS MARKET, BY CALCIUM SULFATE, 2022-2030 (IN $ MILLION)
  • FIGURE 33: EUROPE BIOMATERIALS MARKET, BY ZIRCONIA, 2022-2030 (IN $ MILLION)
  • FIGURE 34: EUROPE BIOMATERIALS MARKET, BY CARBON, 2022-2030 (IN $ MILLION)
  • FIGURE 35: EUROPE BIOMATERIALS MARKET, BY GLASS, 2022-2030 (IN $ MILLION)
  • FIGURE 36: EUROPE BIOMATERIALS MARKET, BY NATURAL BIOMATERIALS, 2022-2030 (IN $ MILLION)
  • FIGURE 37: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY NATURAL BIOMATERIALS, IN 2021
  • FIGURE 38: EUROPE BIOMATERIALS MARKET, BY HYALURONIC ACID, 2022-2030 (IN $ MILLION)
  • FIGURE 39: EUROPE BIOMATERIALS MARKET, BY FIBRIN, 2022-2030 (IN $ MILLION)
  • FIGURE 40: EUROPE BIOMATERIALS MARKET, BY COLLAGEN & GELATIN, 2022-2030 (IN $ MILLION)
  • FIGURE 41: EUROPE BIOMATERIALS MARKET, BY CELLULOSE, 2022-2030 (IN $ MILLION)
  • FIGURE 42: EUROPE BIOMATERIALS MARKET, BY CHITIN, 2022-2030 (IN $ MILLION)
  • FIGURE 43: EUROPE BIOMATERIALS MARKET, BY ALGINATES, 2022-2030 (IN $ MILLION)
  • FIGURE 44: EUROPE BIOMATERIALS MARKET, BY SILK, 2022-2030 (IN $ MILLION)
  • FIGURE 45: EUROPE BIOMATERIALS MARKET, BY INORGANIC GLASS-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
  • FIGURE 46: EUROPE BIOMATERIALS MARKET, BY RADIOPAQUE BIOMATERIALS, 2022-2030 (IN $ MILLION)
  • FIGURE 47: EUROPE BIOMATERIALS MARKET, BY REGENERATIVE BIOMATERIALS, 2022-2030 (IN $ MILLION)
  • FIGURE 48: EUROPE BIOMATERIALS MARKET, BY HYBRID BIOMATERIAL COMBINATIONS, 2022-2030 (IN $ MILLION)
  • FIGURE 49: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
  • FIGURE 50: EUROPE BIOMATERIALS MARKET, BY CARDIOVASCULAR, 2022-2030 (IN $ MILLION)
  • FIGURE 51: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY CARDIOVASCULAR, IN 2021
  • FIGURE 52: EUROPE BIOMATERIALS MARKET, BY CATHETERS, 2022-2030 (IN $ MILLION)
  • FIGURE 53: EUROPE BIOMATERIALS MARKET, BY STENTS, 2022-2030 (IN $ MILLION)
  • FIGURE 54: EUROPE BIOMATERIALS MARKET, BY HEART VALVES, 2022-2030 (IN $ MILLION)
  • FIGURE 55: EUROPE BIOMATERIALS MARKET, BY PACEMAKERS, 2022-2030 (IN $ MILLION)
  • FIGURE 56: EUROPE BIOMATERIALS MARKET, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, 2022-2030 (IN $ MILLION)
  • FIGURE 57: EUROPE BIOMATERIALS MARKET, BY VASCULAR GRAFTS, 2022-2030 (IN $ MILLION)
  • FIGURE 58: EUROPE BIOMATERIALS MARKET, BY GUIDEWIRES, 2022-2030 (IN $ MILLION)
  • FIGURE 59: EUROPE BIOMATERIALS MARKET, BY SENSORS, 2022-2030 (IN $ MILLION)
  • FIGURE 60: EUROPE BIOMATERIALS MARKET, BY ORTHOPEDIC, 2022-2030 (IN $ MILLION)
  • FIGURE 61: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY ORTHOPEDIC, IN 2021
  • FIGURE 62: EUROPE BIOMATERIALS MARKET, BY JOINT REPLACEMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 63: EUROPE BIOMATERIALS MARKET, BY FRACTURE FIXATION, 2022-2030 (IN $ MILLION)
  • FIGURE 64: EUROPE BIOMATERIALS MARKET, BY SPINE ADJUSTMENTS, 2022-2030 (IN $ MILLION)
  • FIGURE 65: EUROPE BIOMATERIALS MARKET, BY ORTHOBIOLOGY, 2022-2030 (IN $ MILLION)
  • FIGURE 66: EUROPE BIOMATERIALS MARKET, BY VISCOSUPPLEMENTATION, 2022-2030 (IN $ MILLION)
  • FIGURE 67: EUROPE BIOMATERIALS MARKET, BY BIORESORBABLE TISSUE FIXATION, 2022-2030 (IN $ MILLION)
  • FIGURE 68: EUROPE BIOMATERIALS MARKET, BY OPHTHALMOLOGY, 2022-2030 (IN $ MILLION)
  • FIGURE 69: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY OPHTHALMOLOGY, IN 2021
  • FIGURE 70: EUROPE BIOMATERIALS MARKET, BY CONTACT LENSES, 2022-2030 (IN $ MILLION)
  • FIGURE 71: EUROPE BIOMATERIALS MARKET, BY INTRAOCULAR LENSES, 2022-2030 (IN $ MILLION)
  • FIGURE 72: EUROPE BIOMATERIALS MARKET, BY FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, 2022-2030 (IN $ MILLION)
  • FIGURE 73: EUROPE BIOMATERIALS MARKET, BY SYNTHETIC CORNEAS, 2022-2030 (IN $ MILLION)
  • FIGURE 74: EUROPE BIOMATERIALS MARKET, BY OTHER OPHTHALMOLOGY APPLICATIONS, 2022-2030 (IN $ MILLION)
  • FIGURE 75: EUROPE BIOMATERIALS MARKET, BY DENTAL, 2022-2030 (IN $ MILLION)
  • FIGURE 76: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY DENTAL, IN 2021
  • FIGURE 77: EUROPE BIOMATERIALS MARKET, BY DENTAL BONE GRAFTS AND SUBSTITUTES, 2022-2030 (IN $ MILLION)
  • FIGURE 78: EUROPE BIOMATERIALS MARKET, BY DENTAL MEMBRANES, 2022-2030 (IN $ MILLION)
  • FIGURE 79: EUROPE BIOMATERIALS MARKET, BY WOUND HEALING, 2022-2030 (IN $ MILLION)
  • FIGURE 80: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY WOUND HEALING, IN 2021
  • FIGURE 81: EUROPE BIOMATERIALS MARKET, BY STAPLES, 2022-2030 (IN $ MILLION)
  • FIGURE 82: EUROPE BIOMATERIALS MARKET, BY WOUND CLOSURE DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 83: EUROPE BIOMATERIALS MARKET, BY SUTURES, 2022-2030 (IN $ MILLION)
  • FIGURE 84: EUROPE BIOMATERIALS MARKET, BY HERNIA MESHES, 2022-2030 (IN $ MILLION)
  • FIGURE 85: EUROPE BIOMATERIALS MARKET, BY SURGICAL HAEMOSTATS, 2022-2030 (IN $ MILLION)
  • FIGURE 86: EUROPE BIOMATERIALS MARKET, BY INTERNAL TISSUE SEALANTS, 2022-2030 (IN $ MILLION)
  • FIGURE 87: EUROPE BIOMATERIALS MARKET, BY ADHESION BARRIERS, 2022-2030 (IN $ MILLION)
  • FIGURE 88: EUROPE BIOMATERIALS MARKET, BY PLASTIC SURGERIES, 2022-2030 (IN $ MILLION)
  • FIGURE 89: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY PLASTIC SURGERIES, IN 2021
  • FIGURE 90: EUROPE BIOMATERIALS MARKET, BY CRANIOFACIAL SURGERIES, 2022-2030 (IN $ MILLION)
  • FIGURE 91: EUROPE BIOMATERIALS MARKET, BY SOFT-TISSUE FILLERS, 2022-2030 (IN $ MILLION)
  • FIGURE 92: EUROPE BIOMATERIALS MARKET, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, 2022-2030 (IN $ MILLION)
  • FIGURE 93: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, IN 2021
  • FIGURE 94: EUROPE BIOMATERIALS MARKET, BY SHUNTING SYSTEMS, 2022-2030 (IN $ MILLION)
  • FIGURE 95: EUROPE BIOMATERIALS MARKET, BY NEURAL STEM CELL ENCAPSULATION, 2022-2030 (IN $ MILLION)
  • FIGURE 96: EUROPE BIOMATERIALS MARKET, BY CORTICAL NEURAL PROSTHETICS (CNP), 2022-2030 (IN $ MILLION)
  • FIGURE 97: EUROPE BIOMATERIALS MARKET, BY HYDROGEL SCAFFOLDS, 2022-2030 (IN $ MILLION)
  • FIGURE 98: EUROPE BIOMATERIALS MARKET, BY TISSUE ENGINEERING, 2022-2030 (IN $ MILLION)
  • FIGURE 99: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY TISSUE ENGINEERING, IN 2021
  • FIGURE 100: EUROPE BIOMATERIALS MARKET, BY TAILORING OF INORGANIC NANOPARTICLES, 2022-2030 (IN $ MILLION)
  • FIGURE 101: EUROPE BIOMATERIALS MARKET, BY SCAFFOLDS FOR REGENERATIVE MEDICINE, 2022-2030 (IN $ MILLION)
  • FIGURE 102: EUROPE BIOMATERIALS MARKET, BY NANOMATERIAL FOR BIOSENSING, 2022-2030 (IN $ MILLION)
  • FIGURE 103: EUROPE BIOMATERIALS MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
  • FIGURE 104: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY OTHER APPLICATIONS, IN 2021
  • FIGURE 105: EUROPE BIOMATERIALS MARKET, BY URINARY APPLICATIONS, 2022-2030 (IN $ MILLION)
  • FIGURE 106: EUROPE BIOMATERIALS MARKET, BY DRUG DELIVERY SYSTEMS, 2022-2030 (IN $ MILLION)
  • FIGURE 107: EUROPE BIOMATERIALS MARKET, BY BARIATRIC SURGERIES, 2022-2030 (IN $ MILLION)
  • FIGURE 108: EUROPE BIOMATERIALS MARKET, BY GASTROINTESTINAL APPLICATIONS, 2022-2030 (IN $ MILLION)
  • FIGURE 109: EUROPE BIOMATERIALS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 110: UNITED KINGDOM BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 111: GERMANY BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 112: FRANCE BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 113: ITALY BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 114: RUSSIA BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 115: BELGIUM BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 116: POLAND BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 117: REST OF EUROPE BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!